Live News Categoriesequity

Medicenna Therapeutics Corp. (MDNA.TO) News

Track canonical SquawkNews coverage tagged to MDNA.TO, Medicenna Therapeutics Corp.. This hub brings together deduplicated headlines about toronto, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 1 indexed stories across 1 publication days and is ordered by the same first-publication timeline used by LiveCast.

Symbol MDNA.TO Asset equity Sector Markets 90 days 1 Last 0.405 Updated Sep 24, 2026, 11:05 AM UTC Open live news feed

L Medicenna says new bizaxofusp survival data in recurrent glioblastoma set for SNO 2026 oral presentation Medicenna flagged new survival analysis for bizaxofusp in unresectable IDH-wildtype recurrent glioblastoma selected for an oral presentation. Results have not been presented yet; the readout is scheduled for Nov. 13, 202 NEWS | Sep 24, 2026, 11:05 AM UTC